AU Stock MarketDetailed Quotes

NSB Neuroscientific Biopharmaceuticals Ltd

Watchlist

0.036
0.0000.00%

20min DelayMarket Closed Nov 14 13:54 AET

5.21MMarket Cap18.00P/E (Static)

Neuroscientific Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

Operating cash flow (direct method)

Cash income from operating activities

-55.34%2.21M

4.95M

2,411.67%1.02M

19.77%40.54K

33.85K

Revenue from customers

----

--4.95M

----

2,411.67%1.02M

19.77%40.54K

--33.85K

Income from government grants

--2.21M

----

Cash paid

68.74%-2.3M

-5.05%-7.36M

-92.21%-7.01M

-54.94%-3.65M

-54.24%-2.35M

-1.53M

Payments to suppliers for goods and services

68.74%-2.3M

-5.05%-7.36M

-92.21%-7.01M

-54.94%-3.65M

-54.24%-2.35M

---1.53M

Direct interest paid

200.00%157

---157

----

98.16%-63

-634.84%-3.42K

---465

Direct interest received

24.94%134.35K

57.09%107.53K

147.60%68.45K

-22.63%27.65K

-58.18%35.73K

--85.44K

Operating cash flow

101.92%44.25K

66.81%-2.3M

-166.85%-6.94M

-14.04%-2.6M

-62.09%-2.28M

---1.41M

Investing cash flow

Cash flow from continuing investing activities

-1.82K

87.06%-3.87K

-1,154.32%-29.88K

87.52%-2.38K

-19.08K

Net PPE purchase and sale

---1.82K

----

87.06%-3.87K

-1,154.32%-29.88K

87.52%-2.38K

---19.08K

Cash from discontinued investing activities

Investing cash flow

---1.82K

----

87.06%-3.87K

-1,154.32%-29.88K

87.52%-2.38K

---19.08K

Financing cash flow

Cash flow from continuing financing activities

1,305.79%13.51M

-83.80%960.8K

5.93M

Net common stock issuance

----

1,305.79%13.51M

-83.80%960.8K

--5.93M

Cash from discontinued financing activities

Financing cash flow

--0

----

1,305.79%13.51M

-83.80%960.8K

--5.93M

Net cash flow

Beginning cash position

-31.93%4.91M

-49.05%7.22M

330.88%14.16M

-28.70%3.29M

4,336.85%4.61M

--103.9K

Current changes in cash

101.84%42.43K

66.83%-2.3M

-163.87%-6.95M

922.14%10.88M

-129.36%-1.32M

--4.51M

End cash Position

0.86%4.95M

-31.93%4.91M

-49.05%7.22M

330.88%14.16M

-28.70%3.29M

--4.61M

Free cash from

101.84%42.43K

66.83%-2.3M

-163.97%-6.95M

-15.23%-2.63M

-60.09%-2.28M

---1.43M

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities	-55.34%2.21M	4.95M		2,411.67%1.02M	19.77%40.54K	33.85K
Revenue from customers	----	--4.95M	----	2,411.67%1.02M	19.77%40.54K	--33.85K
Income from government grants	--2.21M	----	----	----	----	----
Cash paid	68.74%-2.3M	-5.05%-7.36M	-92.21%-7.01M	-54.94%-3.65M	-54.24%-2.35M	-1.53M
Payments to suppliers for goods and services	68.74%-2.3M	-5.05%-7.36M	-92.21%-7.01M	-54.94%-3.65M	-54.24%-2.35M	---1.53M
Direct interest paid	200.00%157	---157	----	98.16%-63	-634.84%-3.42K	---465
Direct interest received	24.94%134.35K	57.09%107.53K	147.60%68.45K	-22.63%27.65K	-58.18%35.73K	--85.44K
Operating cash flow	101.92%44.25K	66.81%-2.3M	-166.85%-6.94M	-14.04%-2.6M	-62.09%-2.28M	---1.41M
Investing cash flow
Cash flow from continuing investing activities	-1.82K		87.06%-3.87K	-1,154.32%-29.88K	87.52%-2.38K	-19.08K
Net PPE purchase and sale	---1.82K	----	87.06%-3.87K	-1,154.32%-29.88K	87.52%-2.38K	---19.08K
Cash from discontinued investing activities
Investing cash flow	---1.82K	----	87.06%-3.87K	-1,154.32%-29.88K	87.52%-2.38K	---19.08K
Financing cash flow
Cash flow from continuing financing activities	0			1,305.79%13.51M	-83.80%960.8K	5.93M
Net common stock issuance	----	----	----	1,305.79%13.51M	-83.80%960.8K	--5.93M
Cash from discontinued financing activities
Financing cash flow	--0	----	----	1,305.79%13.51M	-83.80%960.8K	--5.93M
Net cash flow
Beginning cash position	-31.93%4.91M	-49.05%7.22M	330.88%14.16M	-28.70%3.29M	4,336.85%4.61M	--103.9K
Current changes in cash	101.84%42.43K	66.83%-2.3M	-163.87%-6.95M	922.14%10.88M	-129.36%-1.32M	--4.51M
End cash Position	0.86%4.95M	-31.93%4.91M	-49.05%7.22M	330.88%14.16M	-28.70%3.29M	--4.61M
Free cash from	101.84%42.43K	66.83%-2.3M	-163.97%-6.95M	-15.23%-2.63M	-60.09%-2.28M	---1.43M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data